Orsiro
Orsiro is a medical device with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
SORT OUT X - Combo Stent Versus ORSIRO Stent
Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT)
The SORT OUT IX STEMI OCT Trial
BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX
A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Clinical Trials (8)
SORT OUT X - Combo Stent Versus ORSIRO Stent
Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT)
The SORT OUT IX STEMI OCT Trial
BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX
A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
BIOFLOW-III UK Satellite Registry Orsiro Stent System
ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography
Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents
All 8 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 8